Bridging the Access Gap: Expanded Access Programs for Patients in Need
We navigate complex regulatory landscapes to facilitate access to investigational therapies for patients with unmet medical needs.
Our services encompass patient identification, program development, and ongoing support to ensure the safety and well-being of participating patients.
We collaborate closely with physicians, healthcare providers, and regulatory authorities to ensure seamless program implementation and compliance.
By choosing SPS Pharma for your EAP needs, you can improve patient access, meet ethical obligations, and advance the development of promising new therapies.
Our services include:
We collaborate with pharmaceutical and biotech companies to:
- Bridge the access gap: Provide timely access to investigational therapies while navigating local regulatory approvals.
- Maintain patient access: Support long-term access for patients in situations where traditional registration pathways are not feasible.
- Ensure patient safety: Maintain the highest standards of quality, safety, and risk management throughout the EAP.
How we operate
We guarantee top-quality standards to ensure the safe and prompt delivery of pharmaceutical products.
We ensure a fast decision-making process and strict compliance with delivery deadlines.
We optimize each project through cost-effective offers and logistical solutions.
Each of our clients receives a personalized approach, allowing us to adapt to the specific needs of the project and choose the best partnership model.
We use cutting-edge technologies and monitoring systems to ensure the safety and integrity of every delivery.
We use a proactive approach in quality management, which allows us to identify potential issues and take measures to prevent them.
